Egalet (STU:EGP) Days Payable: 474.01 (As of Mar. 2020) — 17% Below Median


What is Egalet Days Payable?

Egalet STU:EGP Days Payable is 474.01 as of Mar. 2020, which is 17% below its 10-year median of 569.63. The stock has 2 warning signs investors should review.

Egalet's average Accounts Payable for the three months ended in Mar. 2020 was €16.19 Mil. Egalet's Cost of Goods Sold for the three months ended in Mar. 2020 was €3.12 Mil. Hence, Egalet's Days Payable for the three months ended in Mar. 2020 was 474.01.

The historical rank and industry rank for Egalet's Days Payable or its related term are showing as below:

STU:EGP' s Days Payable Range Over the Past 10 Years
Min: 238.55   Med: 569.63   Max: 827.64
Current: 301.03

During the past 9 years, Egalet's highest Days Payable was 827.64. The lowest was 238.55. And the median was 569.63.

STU:EGP's Days Payable is not ranked
in the Drug Manufacturers industry.
Industry Median: 90.69 vs STU:EGP: 301.03

Egalet's Days Payable increased from Mar. 2019 (0.00) to Mar. 2020 (474.01). It may suggest that Egalet delayed paying its suppliers.

Egalet Days Payable Historical Data

* Premium members only.

The historical data trend for Egalet's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Egalet Days Payable Chart

Egalet Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Days Payable
Get a 7-Day Free Trial Premium Member Only 621.22 477.39 454.91 449.14 0.00

Egalet Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 59.82 99.39 0.00 474.01

STU:EGP vs CPHI, TLGT, KGKG: Days Payable Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Egalet's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Egalet Days Payable vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Egalet's Days Payable distribution charts can be found below:

* The bar in red indicates where Egalet's Days Payable falls into.


Egalet Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Egalet's Days Payable for the fiscal year that ended in Dec. 2019 is calculated as

Days Payable (A: Dec. 2019 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2018 ) + Accounts Payable (A: Dec. 2019 )) / count ) / Cost of Goods Sold (A: Dec. 2019 )*Days in Period
=( (7.525 + 11.477) / 2 ) / 0*365
=9.501 / 0*365
=N/A

Egalet's Days Payable for the quarter that ended in Mar. 2020 is calculated as:

Days Payable (Q: Mar. 2020 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2019 ) + Accounts Payable (Q: Mar. 2020 )) / count ) / Cost of Goods Sold (Q: Mar. 2020 )*Days in Period
=( (11.477 + 20.906) / 2 ) / 3.117*365 / 4
=16.1915 / 3.117*365 / 4
=474.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 474.01 mean?
Egalet (STU:EGP) has a Days Payable of 474.01 as of Mar. 2020. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Egalet and its competitors. This is 17% below median its historical median of 569.63. Over the past decade, Egalet's Days Payable has ranged from 238.55 to 827.64.
Is Egalet's Days Payable too high?
Egalet's current Days Payable of 474.01 is 17% below median its 10-year median of 569.63. Over the past 10 years, this metric has ranged from a low of 238.55 to a high of 827.64. The Drug Manufacturers industry median Days Payable is 90.69. Egalet's value of 474.01 is 422.7% above this industry median.
How does Egalet's Days Payable compare to CPHI and TLGT?
Egalet's Days Payable of 474.01 can be compared against companies in the Drug Manufacturers industry. The industry median Days Payable is 90.69. Egalet's value of 474.01 is 422.7% above this benchmark. Historically, Egalet's own Days Payable has ranged from 238.55 to 827.64 over the past decade. While the company's 10-year median is 569.63 vs. the industry median of 90.69, Egalet has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.69, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Egalet's current Days Payable of 474.01 is 422.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Egalet and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Egalet's current Days Payable is 474.01, which is 17% below median its own 10-year median of 569.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Egalet stock overvalued right now?
Egalet (STU:EGP) has a current Days Payable of 474.01. The current Days Payable is 474.01, which is 17% below median its 10-year median of 569.63 and 422.7% above the Drug Manufacturers industry median of 90.69. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Egalet (STU:EGP), the current Days Payable is 474.01 as of Mar. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Egalet Business Description

Address 600 Lee Road, Suite 100, Wayne, PA, USA, 19087
Zyla Life Sciences is a U.S based company focused on marketing its portfolio of medicines for pain and inflammation. The products offered by the company include Sprix, Oxaydo, Vivlodex, Zorvolex, Tivorbex and Indocin Oral Suspension among others.